Advisory Services Network LLC Decreases Stake in DaVita Inc. (NYSE:DVA)

Advisory Services Network LLC reduced its stake in shares of DaVita Inc. (NYSE:DVA - Free Report) by 41.2% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 5,273 shares of the company's stock after selling 3,688 shares during the period. Advisory Services Network LLC's holdings in DaVita were worth $789,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. SBI Securities Co. Ltd. bought a new position in shares of DaVita during the fourth quarter worth about $41,000. Venturi Wealth Management LLC increased its position in DaVita by 59.8% during the 4th quarter. Venturi Wealth Management LLC now owns 406 shares of the company's stock valued at $61,000 after purchasing an additional 152 shares during the period. Versant Capital Management Inc lifted its position in shares of DaVita by 58.7% in the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company's stock worth $68,000 after purchasing an additional 169 shares during the period. Blue Trust Inc. boosted its stake in shares of DaVita by 39.7% in the 4th quarter. Blue Trust Inc. now owns 461 shares of the company's stock valued at $76,000 after purchasing an additional 131 shares during the last quarter. Finally, Jones Financial Companies Lllp increased its position in shares of DaVita by 28.6% during the fourth quarter. Jones Financial Companies Lllp now owns 517 shares of the company's stock worth $77,000 after buying an additional 115 shares during the period. 90.12% of the stock is owned by institutional investors and hedge funds.

DaVita Stock Down 0.9 %

Shares of DVA traded down $1.29 during trading hours on Friday, hitting $140.21. The stock had a trading volume of 994,193 shares, compared to its average volume of 834,677. DaVita Inc. has a 1-year low of $128.69 and a 1-year high of $179.60. The firm has a market capitalization of $11.22 billion, a P/E ratio of 13.05, a price-to-earnings-growth ratio of 1.07 and a beta of 1.04. The firm has a 50 day simple moving average of $149.13 and a 200-day simple moving average of $155.97. The company has a debt-to-equity ratio of 23.18, a current ratio of 1.26 and a quick ratio of 1.21.

DaVita (NYSE:DVA - Get Free Report) last announced its quarterly earnings data on Thursday, February 13th. The company reported $2.24 EPS for the quarter, beating analysts' consensus estimates of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. Sell-side analysts predict that DaVita Inc. will post 10.76 EPS for the current fiscal year.

Analyst Ratings Changes

Several research firms recently issued reports on DVA. Barclays boosted their target price on shares of DaVita from $164.00 to $169.00 and gave the company an "equal weight" rating in a report on Tuesday, February 18th. Cowen reissued a "hold" rating on shares of DaVita in a research note on Tuesday, February 18th. StockNews.com raised DaVita from a "hold" rating to a "buy" rating in a research note on Thursday, April 10th. Finally, Sanford C. Bernstein set a $184.00 target price on DaVita in a report on Friday, February 21st. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and two have issued a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus price target of $166.33.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.